Effects of combination therapy with verteporfin photodynamic therapy and ranibizumab in patients with age-related macular degeneration

Wolf-Schnurrbusch, Ute E K; Brinkmann, Christian K; Berger, Lisa; Wolf, Sebastian (2011). Effects of combination therapy with verteporfin photodynamic therapy and ranibizumab in patients with age-related macular degeneration. Acta ophthalmologica, 89(6), pp. 585-90. Oxford: Blackwell Munksgaard 10.1111/j.1600-0420.2004.00382.x

Full text not available from this repository. (Request a copy)

This open-label, prospective, small-scale study investigated the benefits of same-day verteporfin and intravitreal ranibizumab in patients with predominantly classic, minimally classic or occult subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology

UniBE Contributor:

Wolf-Schnurrbusch, Ute; Berger, Lieselotte Erika and Wolf, Sebastian

ISSN:

1755-375X

Publisher:

Blackwell Munksgaard

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:07

Last Modified:

06 Dec 2013 13:19

Publisher DOI:

10.1111/j.1600-0420.2004.00382.x

PubMed ID:

19878113

Web of Science ID:

000226093000004

URI:

https://boris.unibe.ch/id/eprint/272 (FactScience: 197255)

Actions (login required)

Edit item Edit item
Provide Feedback